期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

MELD评分联合Child-Pugh分级评估失代偿期肝硬化患者预后 被引量：2

下载PDF
导出
摘要 目的评估终末期肝病模型(MELD)与Child-Pugh评分系统对失代偿期肝硬化患者预后评估的价值。方法回顾2001年8月-2008年2月收治的具有完整临床资料的失代偿期肝硬化住院患者101例,其中死亡(A组)35例,存活(B组)66例,将2组患者入院及出院时MELD和Child-Pugh评分进行比较。结果MELD评分:A组为(17.63±2.61)分,B组为(12.53±2.96)分,2组比较差异有统计学意义(P<0.01)。Child-Pugh评分:A组为(12.87±2.05)分,B组为(7.93±1.89)分,2组比较差异有统计学意义(P<0.01)。MELD评分越高,病死率越高(P<0.01);Child-Pugh评分越高,病死率亦越高(P<0.01)。结论MELD评分及Child-Pugh分级均可对失代偿期肝硬化患者病情严重程度及预后做出评估。
作者 官亮 朱水山 邓薇 文艺
机构地区 南昌大学第四附属医院消化科 南昌大学第二附属医院消化科
出处 《实用临床医学（江西）》 CAS 2008年第12期38-40,共3页 Practical Clinical Medicine
关键词 终末期肝病模型 CHILD-PUGH分级 肝硬化 失代偿期 预后
分类号 R575.2 [医药卫生—消化系统]
  • 相关文献

参考文献9

  • 1Kamath P S, Wiesner R H, Malinchoc M, et al. A Model to Predict Survival in Patients with End-stage Liver Disease[J]. Hepatology, 2001,33 : 464-470.
  • 2中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量：14009
  • 3Dympna K, Khavir S, Russell S. Predicting Survival in Endstage Liver Disease[J]. Eviclence-Based Gastroenterology, 2001,2(2) :94-95.
  • 4林栋栋,李铎,孙家邦.一种终末期肝病的危险度评分模型[J].中华肝脏病杂志,2004,12(4):253-254. 被引量：16
  • 5Oellerieh M,Burdelski M ,Lautz H U,et al. Predictors of Oneyear Pretransplant Survival in Patients with Cirrhosis[J]. Hepatology, 1991,14 : 1029-1034.
  • 6Wiesner R,Edwards E,Freeman R,et al. Model for End-Stage Liver Disease(MELD) and Allocation of Donor Livers[J]. Gastroenterology, 2003,124 : 91-96.
  • 7Merion R M,Wolfe R A,Dykstra D M. et al. Longitudinal Assessment of Mortality Risk among Candidates for Liver Transplantation[J]. Liver Transpl, 2003,9 ( 1 ) : 12-18.
  • 8Forman L M,Lucey M R. Predicting the Prognosis of Chronic Liver Disease:an Evolution from Child to MELD[J]. Hepatology,2001,33 : 473-475.
  • 9Reuben A. Child Comes of Age[J]. Hepatology, 2002, 35: 244-245.

二级参考文献11

  • 1Kamath PS, McKusick MA. Transvenous introhepatic portosystemic shunts. Gastroenterology, 1996, 111: 1700-1705.
  • 2Patch D, Nikolopoulou V, McCormick A, et al. Factors related to early mortality after transjugular intahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol,1998, 28: 454-460.
  • 3Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from Child to MELD. Hepatology, 2001, 33:473-475.
  • 4Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 2000, 31: 864-871.
  • 5Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001,33: 464-470.
  • 6Salerno F, Merli M, Cazzaniga M, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatology,2002, 36: 494-500.
  • 7Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD:application of suivival models to liver allocation. Liver Transpl,2001, 7: 567-580.
  • 8Freeman RB, Edwards EB. Liver transplant waiting time dose not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl, 2000, 6: 543-552.
  • 9Cheng S J, Freeman RB, Wong JB. Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma.Liver Transpl, 2002, 8: 323-328.
  • 10Brown RS, Kumar KS, Russo MW, et al. Model for End-Stage Liver Disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, postransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A p

共引文献14016

同被引文献20

引证文献2

二级引证文献7

实用临床医学（江西）
2008年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部